Bortezomib-induced thrombotic thrombocytopaenic purpura

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Mehta, Neha ^a   Saxena, Ashish ^a   Niesvizky, Ruben ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HEMOGLOBIN; IMMUNOGLOBULIN A; LENALIDOMIDE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY TUBULE NECROSIS; AGED; ANURIA; ARTICLE; CASE REPORT; CONFUSION; DEHYDRATION; DIARRHEA; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; FOOD INTAKE; HEMODIALYSIS; HUMAN; HYPERBILIRUBINEMIA; HYPERTENSION; HYPERVISCOSITY SYNDROME; INTRAVASCULAR HEMOLYSIS; LETHARGY; MOOD DISORDER; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINALYSIS; URINE COLOR; WEAKNESS;

EID: 84865448833     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006461     Document Type: Article

References (10)

1. Zakarija A, Bennett C. Drug-Induced thrombotic microangiopathy. Semin Thromb Hemost 2005;31:681-90. (Pubitemid 43063086)
2. Gottshall JL, Neahring B, McFarland JG, et al. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol 1994;47:283-9. (Pubitemid 24372282)
3. Reeder CB, Reece DE, Kukreti V, et al. Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial. Leukemia 2009;23:1337-41.
4. Morita R, Hashino S, Shirai S, et al. Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma. Int J Hematol 2008;88:248-50.
5. Moore H, Romeril K. Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib. J Int Med 2011;41:348-50.
6. Zheng XL, Kaufman RM, Goodnough LT, et al. Effect of plasma exchange on ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004;103:4043-9. (Pubitemid 38685342)
7. Lesesne JB, Rothschild N, Erickson B, et al. Cancer associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989;7:781-9. (Pubitemid 19145601)
8. George J. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000;96:1223-9. (Pubitemid 30658447)
9. Pham PT, Peng A, Wilkinson AH, et al. Cyclosporine and tacrolimus associated thrombotic microangiopathy. Am J Kidney Dis 2000;36:844-50.
10. Zakarija A, Bandarenko N, Pandey DK, et al. Clopidogrel-associated TTP: an update of pharmacovigalance efforts conducted by independent researchers, pharmaceutical suppliers and the Food and Drug Administration. Stroke 2004;35:533-7. (Pubitemid 38174443)